AML-MDS Novel Prognostic Tests Clinical Study

NCT01685619 · clinicaltrials.gov ↗

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia (AML)
Myelodysplastic Syndrome (MDS)

Sponsor

Nova Scotia Health Authority

Collaborators

[object Object]